Latest filing published 08 Jan 2024 for Athira Pharma, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Hans Moebius: trading record in brief
All filings by Hans Moebius on record concern LeonaBio, Inc., in the capacity of senior executive. We count 12 filings; the first trade dates from 18 May 2021 and the latest from 4 January 2024.
The open-market record is one-sided, with 2 purchases worth €43k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 6 share grants and 4 option exercises.
The newest entry dates from 8 January 2024: a share grant, in LeonaBio, Inc. The latest purchase dates back some time: it was published 1,453 days ago, on 17 November 2022. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Hans Moebius
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares0Common StockSEC:0001209191-24-001157:0
- 7,764 shares@ US$2.4110.9% of flowCommon StockSEC:0001209191-23-034886:0
- 7,882 shares@ US$1.356.2% of flowCommon StockSEC:0001209191-23-034886:1
- 5,000 shares@ US$3.288410.0% of flowCommon StockSEC:0001209191-22-057721:0Canonical exit: 13 Feb 2023 (T+90)
- 7,881 shares@ US$1.356.8% of flowCommon StockSEC:0001209191-22-053869:0
- 10,000 shares@ US$2.8825.9% of flowCommon StockSEC:0001209191-22-039937:0Canonical exit: 26 Sept 2022 (T+90)
- 1,699 shares@ US$7.0610.8% of flowCommon StockSEC:0001209191-22-039343:0
- 829 shares@ US$12.517.2% of flowCommon StockSEC:0001209191-22-004120:0
- 2,055 shares@ US$14.4519.2% of flowCommon StockSEC:0001209191-21-047601:0
9 of 9 declarations
